Neuron-Astrocyte Interactions in Parkinson’s Disease

Cited by (186)

Items 101–186 of 186

  1. New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and Neuroprotection
    Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, Savanah Descôteaux, Maria‐Grazia Martinoli · 2022 · Current Pharmaceutical Design
  2. Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson’s Disease Pathogenesis
    Xuanxiang Jin, Xiaoli Si, Xiaoguang Lei, Huifang Liu, Anwen Shao, Lingfei Li · 2023 · Aging and Disease
  3. Double-edged effect of astrocyte in the transition of physiopathological states in Parkinson’s disease
    Zilu Cao, Lin Du, Honghui Zhang, Zhuan Shen, Zichen Deng · 2024 · Chaos Solitons & Fractals
  4. Astrocyte-Neuron Metabolic Synergies in Neurological Homeostasis and Disease
    Jiahao Dong, Zihan Gao, Mingrui Liu, Binglu Qian, Cheng Yuan, Hui Liu, Ni Rao, Yingjiao Liu · 2025 · Neurochemical Research
  5. Kynurenine pathway in Parkinson’s disease: pathophysiological roles and therapeutic interventions
    Aganta Chakraborty, Priya Chaudhary, Joy Das, Utpal Bhui, Khadga Raj Aran, Md Sadique Hussain, Sumel Ashique, Biplab Debnath · 2025 · Inflammopharmacology
  6. Deciphering Ferroptosis-Related Astrocyte Subpopulations and Diagnostic Biomarkers in Parkinson’s Disease through RNA Transcriptomics
    Zhongying Gong, Dan Guo, Yufeng Lin, Zhiwei Liu, Mingyue Lv, Xinxin Liu, Mingshuo Sun, Linlin Wang, Tianman Zhao, Zhiyun Wang et al. · 2025 · Molecular Neurobiology
  7. Programmed cell death pathways in Parkinson’s disease: Spotlight on ferroptosis and pyroptosis
    Veerta Sharma, Reet Verma, Prateek Sharma, Takveer Singh · 2026 · Brain Research
  8. The Possible Impact of Montelukast in Parkinson’s Disease: A Substantial Contribution
    Areej Ahmed Turkistani, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Duaa Eliwa, Athanasios Alexiou, Hala Alnoaman, Marios Papadakis, Gaber El‐Saber Batiha · 2026 · Journal of Geriatric Psychiatry and Neurology
  9. Role of neuron specific enolase as a biomarker in Parkinson’s disease
    Rajib Dutta · 2021 · Journal of Neuroscience and Neurological Disorders
  10. Targeting the pathogenesis and boosting the therapeutic efficacy of Parkinson's disease by advanced nanoparticles
    Hanghang Liu, Menglong Hua, Qing Yin Zheng, Yifan Gao, Zhen Li · 2023 · MedComm – Biomaterials and Applications
  11. Role of astrocytes in Alzheimer's disease pathogenesis and the impact of exercise-induced remodeling
    Jie Shao, Qianting Deng, Shu Feng, Chongyun Wu, Xiaocao Liu, Luodan Yang · 2024 · Biochemical and Biophysical Research Communications
  12. Research progress on the role of exercise-regulated reactive astrocytes in the prevention and treatment of Parkinson’s disease
    Quan Yang, Chunyu Zhuang · 2025 · Frontiers in Aging Neuroscience
  13. Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons
    Sissel Ida Schmidt, Justyna Okarmus, Daniel Aghaie Madsen, Julie Schmidt Hansen, Emil Gregersen, Hjalte Gram, Lucas Seidelin Winkelmann, Anderson Souza Oliveira, Rachel Heon‐Roberts, Brent James Ryan et al. · 2025 · npj Parkinson s Disease
  14. Neuroprotective effects of taurine in a rodent model of parkinson’s disease involve modulating astrocyte-mediated inflammation
    Sung Min Moon, Jaehoon Kim, Jaeheon Seol, Seonguk Yang, Duwon Jung, Chang Yup Kim, Chang Seok Kim, Ki Wung Chung, Young‐Suk Jung, Seung‐Cheol Chang et al. · 2025 · Archives of Pharmacal Research
  15. Intermittent fasting protects MPTP-induced Parkinson's disease mouse model through regulating gut microbiota dysbiosis
    Yewei Qu, Peiru Wang, Dongjie Wang, Bo Li, Fan Yang · 2026 · International Immunopharmacology
  16. Neutralization of Cannabidiol Neurotoxicity in Neuron‐Astrocyte Sandwich Coculture
    Jungnam Kim, Seoin Yang, Insung S. Choi · 2023 · Advanced Biology
  17. Interaction between astrocytes and neurons in simulated space radiation-induced CNS injury
    Mengjin Liu, Yu Lan, Yuhan Qin, Yanan Gao, Yulin Deng, Nuomin Li, Chen Zhang, Hong Ma · 2023 · International Journal of Radiation Biology
  18. Gap Junction Protein Connexin-43 in a Rat Dorsal Root Ganglion
    Elena A. Kolos, D. E. Korzhevsky · 2024 · Cell and Tissue Biology
  19. Neuroprotective effects of different doses of Maresin1 pretreatment in aged rats after anesthesia/surgery
    Xiuhua Li, Xu Han, Yubo Gao, Shaling Tang, Yanfang Yang, Chun Zhang, Xinli Ni · 2023 · Neuroreport
  20. Characterization of Isolated Human Astrocytes from Aging Brain
    Geidy E. Serrano, Sidra Aslam, Jessica E. Walker, Ignazio Stefano Piras, Matthew J. Huentelman, Richard A. Arce, Michael J. Glass, Anthony J. Intorcia, Katsuko E. Suszczewicz, Claryssa I. Borja et al. · 2025 · International Journal of Molecular Sciences
  21. The role of crm-1 in ionizing radiation-induced nervous system dysfunction in Caenorhabditis elegans
    Yu Tu, Na Chen, Huiqiang Long, Jin Gao, Shuqing He, Jianfang Han · 2022 · Neural Regeneration Research
  22. Metformin as a potential neuroprotective agent that influence Parkinson’s disease
    Bhaskar Pal, Niladri Ghatak, Chowdhury Mobaswar Hossain · 2025 · Neurological Sciences
  23. AstroGreen transgenic mouse illuminates the trafficking of astrocyte-derived extracellular vesicles
    Lisa Nieland, Edwina Abou Haidar, David Rufino‐Ramos, Shilpa Prabhakar, Youssef Samaha, Koen Breyne, Francis K. Fordjour, Saumya Das, Marike L. D. Broekman, Stephen J. Gould et al. · 2025 · Molecular and Cellular Neuroscience
  24. Cortical and Striatal Astrocytes of Neonatal Rats Display Distinct Molecular and Pharmacological Characteristics of Dopamine Uptake
    Vesna Sočan, Klemen Dolinar, Mojca Kržan · 2024 · International Journal of Molecular Sciences
  25. The Redox Stress Test: A novel technique reveals oxidative stress in Parkinson’s disease
    Albert F Wright · 2024 · Medical Research Archives
  26. Crosstalk between neurons and glia through G-protein coupled receptors: Insights from Caenorhabditis elegans
    Pratima Pandey, Gazaldeep Kaur, Kavita Babu · 2022 · Progress in molecular biology and translational science
  27. Innate Immunity and Parkinson's Disease
    Davina B. Oludipe, Xiaoqing Du, Samia Akter, Chen Zhang, Rodney Lee Mosley, Howard Eliot Gendelman, Susmita Sil · 2025 · Cold Spring Harbor Perspectives in Medicine
  28. Prader-Willi syndrome protein necdin regulates the nucleocytoplasmic distribution and dopaminergic neuron development
    Xin Li, Yichun Zhang, Ying Hu, Xiangrong Tang, Zishan Gong, Renbin Lu, Jia‐Da Li · 2024 · Scientific Reports
  29. TLR3 activation in astrocytes attenuates the nigrostriatal pathway degeneration in rodent models of Parkinson’s disease
    Jaeyeong Jeong, So-Yoon Won, Young Cheul Chung, Won-Ho Shin, Byung Kwan Jin, Eun S. Park · 2026 · Frontiers in Cellular Neuroscience
  30. Pancreas-brain axis: exploring the pathogenic mechanisms of pancreatic encephalopathy
    Ninan Dai, Zhengguang Geng, Jing Wang, Xiaoli Bu, Ming-Yang Gong, Chang Qin, Yu Zhang, Xiao-Yun Fu, Bao Fu · 2026 · International Immunopharmacology
  31. From necroptosis to neuroinflammation: Unraveling mechanisms and therapeutic targets in age-related cognitive decline
    Leonardo Biscetti, Maria Elsa Gambuzza, Maria Princiotto, Jacopo Sabbatinelli, Fabiola Olivieri, Marco Fiorillo, Chiara Chinigò, Lucia Muglia, Annalisa Cozza, Alessia Beccacece et al. · 2026 · Biomedicine & Pharmacotherapy
  32. Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
    Dianne Marquez Lopez, Lois Keavey, Kathryn R. Bowles · 2026 · Bioscience Reports
  33. C18:0 GM3 ganglioside’s efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation
    Tsung–Ta Liu, Cheng‐Tsung Liu, I‐Hsun Li, Yu-Chieh Chu, Hao-Yuan Hung, Chuang-Hsin Chiu, Ta-Kai Chou, Shiao-Yun Li, Tin-An Wang, Jui‐Hu Shih · 2025 · Behavioral and Brain Functions
  34. Immunity in Parkinson's disease – The role of innate responses
    Aditi S Iyengar, Peter Robert Dunkley, Phillip W. Dickson · 2025 · Journal of Neuroimmunology
  35. Preparation of Primary Mixed Glial Cell Cultures from Adult Mouse Spinal Cord Tissue
    Ling Cao, Elizabeth N. Bean, Jennifer T. Malon · 2023 · Current Protocols
  36. Dynamics of coupled nonlinear neuronal-astrocyte model
    Y Chen, Quanbao Ji · 2024 · AIP Advances
  37. Kinetic Properties and Pharmacological Modulation of High- and Low-Affinity Dopamine Transport in Striatal Astrocytes of Adult Rats
    Vesna Sočan, Klemen Dolinar, Mojca Kržan · 2024 · International Journal of Molecular Sciences
  38. The important role of astrocytes in activity pattern transition of the subthalamopallidal network related to Parkinson's disease
    Yuzhi Zhao, Honghui Zhang, Zilu Cao · 2024 · Electronic Research Archive
  39. Motor impairments and increased GFAP expression in different stages of a progressive model of parkinsonism induced by reserpine
    Edson R. Santos, Thassya Fernanda Oliveira dos Santos, José M.M. Bispo, Milene Cristina de Carvalho, João E.C. Melo, Mylaine S. Mendonça, Katty A.A.L. Medeiros, Alessandra Mussi Ribeiro, Regina H. Silva, Marco Aurélio M. Freire et al. · 2025 · Physiology & Behavior
  40. Neurovascular Coupling in Neurological Disorders: A Comprehensive Review
    Zujuan Ye, Yixiao Wang, Qi Zhang · 2025 · Clinical Neurology and Neuroscience
  41. The Significant Antioxidant Effect Exerted by Pomegranate (Punica granatum): The Hidden Polyphenols
    Rosamaria Caminiti, Valeria Mazza, Jessica Maiuolo, Federico Liuzzi, Francesca Oppedisano, Saverio Nucera, Salvatore Ragusa, Luigi Tucci, Giuseppe Trunfio, Lucia Carmela Passacatini et al. · 2026 · Antioxidants
  42. Genetically Encoded Constitutive Upregulation of β2 Subunit-Containing Neuronal Nicotinic Acetylcholine Receptors Is Neuroprotective in Female Parkinsonian Mice
    Gauri Pandey, Roger C Garcia, Debanjana Das, Akilesh R Mohan, Cristobal Rodriguez, Donovan Pollock, Nethra Karthik, Sushmitha Nalluri, Tan Nguyen, Christopher Polo et al. · 2026 · Journal of Neuroscience
  43. Metabolic reprogramming in sepsis-associated encephalopathy: emerging mechanisms, candidate biomarkers, and future therapeutic directions
    Mei Huang, Weiwei Qian, Daxiu Lin, Yihua Zeng, Yan Zhou, Shurong Zhang, 罗雅玲, Zhi Li, Xiaodong Du · 2026 · Frontiers in Medicine
  44. Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
    Yue Ma, Madalynn L. Erb, Kayla Sipple, Alina V. Offerman, Junwei Niu, Zachary Madaj, Zhen Fu, Kin H. Lau, Darren J. Moore · 2026 · npj Parkinson s Disease
  45. Astrocytes orchestrate neuroprotection and pathogenesis via bidirectional neuronal interactions in Parkinson’s disease
    Yifan Li, Qiang Li, Yemin Wang, Xuejing Wang, Guangfu Di, Meng Niu, Zhiliang Xu, Yanjiao Huang · 2026 · Journal of Physiology and Biochemistry
  46. deCLUTTER2+ – a pipeline to analyze calcium traces in a stem cell model for ventral midbrain patterned astrocytes
    Martyna M. Grochowska, Federico Ferraro, Ana Carreras Mascaro, Domenico Natale, Amber B Winkelaar, Valerie Boumeester, Guido J. Breedveld, Vincenzo Bonifati, Wim J. Mandemakers · 2023 · Disease Models & Mechanisms
  47. The Synergistic Roles of Glial Cells and Non-Coding RNAs in the Pathogenesis of Alzheimer’s Disease and Related Dementias (ADRDs)
    Sydney J. Risen, Devin Wahl, Thomas J. LaRocca, Julie A. Moreno · 2025 · Neuroglia
  48. Neurotoxicants driving glial aging: role of astrocytic aging in non-cell autonomous neurodegeneration
    Pablo Reina-Gonzalez, Muhammet Ay, Monica Renee Langley, Elizabeth C. Plunk, Rachel Strazdins, Abdulla Abu-Salah, Aiesha Anchan, Ahmed Shah, Souvarish Sarkar · 2025 · Toxicological Sciences
  49. Brain Disorder Approach from Neurotransmitters, Neuroinflammation, and RAS Imbalance Perspective
    María Josefina Piermarini, Sol Micaela Angulo, Victoria Belén Occhieppo, Claudia Bregonzio · 2024 · Springer eBooks
  50. Powering the brain in health and disease
    Tamás Kozicz, Éva Morava, Tal Yardeni · 2021 · European Journal of Neuroscience
  51. Development of medical polymers for applications in neurological disorders
    Francisca Espinoza, Walther Ide, Natalia Saldivia, Diego Zelada · 2022 · Elsevier eBooks
  52. deCLUTTER 2+ pipeline to analyze calcium traces in a novel stem cell model for ventral midbrain patterned astrocytes
    Martyna M. Grochowska, Federico Ferraro, Ana Carreras Mascaro, Domenico Natale, Amber B Winkelaar, Valerie Boumeester, Guido J. Breedveld, Vincenzo Bonifati, Wim J. Mandemakers · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Caracterização do perfil astrocitário na substância negra de ratos com discinesia induzida por L-DOPA e tratados com doxiciclina
    Adrielle Ingrid de Oliveira Barbosa Santiago · 2022
  54. GM3 Ganglioside’s Efficacy in LPS-Induced Parkinsonism: Neuroprotection and Gliosis Mitigation
    Tsung–Ta Liu, Li-Yun Fann, I‐Hsun Li, Sheng‐Huang Hsiao, Yu-Chieh Chu, Hao-Yuan Hung, Chih‐Chien Cheng, Ying-Che Huang, Chuang‐Hsin Chiu, Ta-Kai Chou et al. · 2023
  55. Synergistic Action of Vitamin D3 and A Protects Motor Activity by Regulating Reactive Astrocytes, Inflammatory Cytokines, and Dopaminergic Activity in the Corticobasal Loop of a Mice Model of Extrapyramidal Syndrome
    Mujittapha Umar Sirajo, Yahya K. Maigari, Abdulrashid Sunusi, Adam N. Jibril, Isa Usman Lawal, Badamasi Mohammed Ibrahim · 2023 · Research Square
  56. Synergistic action of vitamin D3 and A on motor activity regulation in mice model of extrapyramidal syndrome: Correlational insights into astrocyte regulation, cytokine modulation, and dopaminergic activity
    Mujittapha Umar Sirajo, Yahya K. Maigari, Abdulrashid Sunusi, Adam N. Jibril, Isa Usman Lawal, Badamasi Mohammed Ibrahim · 2024 · Journal of Chemical Neuroanatomy
  57. Gap Junction Protein Connexin-43 in Glial Cells of Rat Dorsal Root Ganglion
    Elena A. Kolos, Dmitriy E. Korzhevsky · 2023 · Tsitologiya
  58. Phytochemicals: Promising Alternatives for Metabolic Regulation in Neurodegenerative Diseases
    Anand Kar, Sunanda Panda · 2024 · Springer eBooks
  59. DJ-1 mediates regulation of metabolism and immune response in Parkinson’s disease astrocytes and Glioblastoma cells
    Pauline Mencke, Jochen Ohnmacht, Félicia Jeannelle, Adrien J Ries, Mónica Miranda de la Maza, Mathilde M. Ullrich, François Massart, Patrycja Mulica, Katja Badanjak, Zoé Hanss et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Parkinson’s Disease and Lewy Body Dementias
    Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2024 · Springer eBooks
  61. Dopamine replacement for Parkinson's disease: Clinical approaches and experimental underpinnings
    M. Angela Cenci, Kristina Rosqvist, Per Odin · 2025 · Handbook of behavioral neuroscience
  62. Establishment and Characterization of Behavioral Changes in the Nuclear Localization Human α-Synuclein Transgenic Mice
    Ziou Wang, M. Wei, Shengtao Fan, Zheli Li, Weihu Long, Haiting Wu, Yiwei Zhang, Zhangqiong Huang · 2025 · Diseases
  63. NLX-112 is anti-inflammatory, upregulates GDNF and is neuroprotective against MPTP-induced nigrostriatal dopaminergic degeneration in mice
    William H. Powell, Lucy E. Annett, Ronan Depoortère, Adrian Newman‐Tancredi, Mahmoud M. Iravani · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Loss of the Parkinson’s disease-associated protein DJ-1 impacts dopamine metabolism in astrocytes
    Annika Wagener, Naiyareen Fareeza Mayeen, Stephan A. Müller, Sarah K. Tschirner, Brigitte Nuscher, Pauline Mencke, Stefan F. Lichtenthaler, Ibrahim Boussaad, Rejko Krüger, Lena F. Burbulla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Additional file 1 of Hypoxia inducible factor-1α regulates microglial innate immune memory and the pathology of Parkinson’s disease
    Hongtian Dong, Zhang, Xiaoshuang, Yufei Duan, He, Yongtao, Jiayin Zhao, Wang, Zishan, Wang, Jinghui, Li, Qing, Guangchun Fan, Liu, Zhaolin et al. · 2024 · Figshare
  66. Additional file 1 of Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways
    Jun Sung Park, Kyonghwan Choe, Hyeon Jin Lee, Tae Ju Park, Kim, Myeong Ok · 2023 · Figshare
  67. Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
    Yue Ma, Madalynn L. Erb, Kayla A. Sipple, Alina V. Offerman, Junwei Niu, Zachary Madaj, Zhen Fu, Kin H. Lau, Darren J. Moore · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Dopaminergic Cell Types Analysis in Parkinson’s Disease
    Daniela Berrelleza, Gustavo Guzmán, Sorpresa Lora-Castro, Omar Paredes, JAlejandro Morales · 2026 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
  69. Speech Motor Deficits in Developmental Stuttering and Parkinson's Disease: From Cellular and Circuit to Network‐Level Disruptions
    Ariana Z. Turk, Marissa Millwater, Sufie Sheikh‐Bahaei, Fatemeh Mollaei, Markus Rießland, Shahriar SheikhBahaei · 2026 · European Journal of Neuroscience
  70. A voxel-level degree centrality study in Parkinson’s disease and the correlation with transcriptomes
    Yuan-Zhi He, Si-Xian Li, Hai-Yu Wang, Zhi Wen · 2026 · Neuroreport
  71. Modeling of neuron-astrocyte interaction : application to signal and image processing
    Jhunlyn Lorenzo · 2022 · theses.fr (ABES)
  72. Contributions à l’étude du rôle des niveaux de vigilance et des états métaboliques cérébraux dans la survenue de crises d’épilepsie absence chez le rat GAERS
    Réda El Mahzoum · 2024 · theses.fr (ABES)
  73. The Small Chemical Compound Repsox Potentiates Oct4-Driven Astrocyte-to-Neural Stem Cell Reprogramming via Notch1/Hes1/Smurf2 Pathway
    Xiaoyu Ma, Zijian Liu, Yuqing He, Dandan Zhang, Peng Deng, Lin Li, Xin Li, Junping Li, Quanrui Ma, Hao Yang · 2026 · Cellular and Molecular Neurobiology
  74. Unravelling the molecular mechanisms of centella asiatica in neurodegeneration: A network pharmacology study on Parkinson’s and Alzheimer’s disease
    D. K. Shanmuganathan, D Hari Pranav, G. Ariharasivakumar · 2026 · In Silico Research in Biomedicine
  75. Tiny Messengers, Big Impact: The Role of Endogenous Extracellular Vesicles in Neurological Diseases
    L. Alzamora, Zhiyu Lin, Wenlu Li, Eng H. Lo · 2026 · Current Neuropharmacology
  76. Peripheral manifestations of nigrostriatal neurodegeneration in Parkinson’s disease
    Jerly Helan Mary Joseph, Mahesh Kandasamy · 2026 · International review of neurobiology
  77. Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps
    Chuan Chen, Kaihua Liu, Meng Xiang, Xueqin Zhang · 2026 · Frontiers in Neurology
  78. LRRK2 Mutation Alters Dopamine D2 Receptor Localization in Induced Pluripotent Stem Cells‐Derived Astrocytes From Parkinson's Disease Patients: Implications for Neuronal Damage
    Veronica Mutti, Federica Bono, Zaira Tomasoni, Dounia Fadel, Chiara Gnutti, Giulia Sbrini, Carolina Gaudenzi, Valentina Salvi, Daniela Bosisio, Isabella Russo et al. · 2026 · Journal of Neurochemistry
  79. Micro- and nanoplastics as environmental modifiers of neuroimmune dysfunction in Parkinson’s disease
    Sichen Qian, Fei Gao, Peng Wang · 2026 · Frontiers in Neuroscience
  80. NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson’s Disease
    William H. Powell, Lucy E. Annett, Ronan Depoortère, Adrian Newman‐Tancredi, Mahmoud M. Iravani · 2026 · ACS Chemical Neuroscience
  81. Dual-Pathway Astrocyte Failure in Parkinson’s Disease: Therapeutic Targeting of Nrf2/TFEB Suppression and cGAS-STING/Ferroptosis Activation
    Ahmed M Abdelaziz · 2026 · Molecular Neurobiology
  82. Unlocking Parkinson’s disease: harnessing the untapped potential of fatty acid metabolism in disease pathogenesis
    Rong Hu, Yaru Song, Ting Liu, Xinyu He, Yi-Yong Qiu, Fanjing Zhong, Xiao Huang, J.J. Huang, Zhigang Jiao · 2026 · Frontiers in Immunology
  83. Convergent Astrocytic Failure in Parkinson’s Disease: A System-Level Model of Pathogenesis and Treatment
    Ahmed M Abdelaziz, Mohamed N Fawzy, Mustafa M Shokr · 2026 · Molecular Neurobiology
  84. AA-2βG attenuates nigrostriatal degeneration and related dopaminergic, redox, and inflammatory alterations in experimental parkinsonism
    Wei Ma, Leping Yan, Jianhua Ding, Yinquan Fang, Gang Hu · 2026 · Neuropharmacology
  85. A ‘brain-first’ mouse model of progressive alpha-synuclein pathology via intranasal rotenone administration
    Monika Sharma, Nishant Sharma, Jhanvi Soni, Manasi Uttarkar, Jana Kučerová, Tiago F. Outeiro, Irena Rektorová, Amit Khairnar · 2026 · npj Parkinson s Disease
  86. Photobiomodulation in Parkinson’s disease: From pathogenesis to intervention
    Jie Shao, Qianting Deng, Luodan Yang · 2026 · Experimental Neurology